Related Experiment Video
Updated: Mar 2, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Cathepsin L activity correlates with proteinuria in chronic kidney disease in humans
1Department of Cardiology, The Third Xiangya Hospital, Central South University, Changsha, 410013, China.
Insights
Serum cathepsin L activity is elevated in chronic kidney disease (CKD) patients and correlates with proteinuria severity and poorer prognosis. This suggests cathepsin L may be a potential biomarker for CKD progression.
Area of Science:
- Nephrology
- Biochemistry
- Clinical Chemistry
Background:
- Proteinuria is a key prognostic marker in chronic kidney disease (CKD), linked to mortality and morbidity.
- Cathepsin L, crucial for kidney ultrafiltration, is upregulated during CKD-related inflammation.
- This study investigated the potential link between proteinuria severity and serum cathepsin L levels in CKD patients.
Purpose of the Study:
- To determine if serum cathepsin L levels correlate with proteinuria severity in CKD patients.
- To assess the potential of cathepsin L as a biomarker for CKD prognosis.
- To explore the association between cathepsin L activity, clinical indicators, and patient outcomes.
Main Methods:
- Retrospective observational study including 135 CKD patients, 31 renal transplant recipients, and 48 healthy controls.
- Analysis of demographic characteristics, clinical indicators, and serum cathepsin L activity.
- ROC analysis to evaluate the diagnostic performance of cathepsin L activity.
Main Results:
- Serum cathepsin L activity was significantly higher in CKD patients compared to controls.
- Higher cathepsin L activity was observed in patients with severe proteinuria and was positively associated with age, BMI, hs-CRP, HMGB1, and 24-h proteinuria.
- Elevated cathepsin L activity correlated with increased hospital admission rates and was lower in patients receiving statin therapy.
Conclusions:
- Serum cathepsin L activity is elevated in CKD patients and correlates with proteinuria severity and prognosis.
- Cathepsin L shows potential as a biomarker for CKD.
- Further prospective studies are warranted to elucidate the clinical implications of serum cathepsin L in CKD management.
Background:
The presence and severity of proteinuria is considered an important prognostic marker in patients with chronic kidney disease (CKD) and is associated with mortality and morbidity. Cathepsin L is highly expressed in the foot processes of podocytes in the kidney, which serves as an ultrafiltration barrier. Cathepsin L is also up-regulated in the setting of inflammation as a feature of CKD. Therefore, we postulated that proteinuria severity in CKD patients might correlate with increased serum levels of cathepsin L.
Methods And Results:
In this retrospective observational study, a total of 135 patients diagnosed with CKD, 31 renal transplant patients and 48 healthy controls were included. The demographic characteristics and clinical indicators were analyzed. Serum cathepsin L activity was significantly higher in patients with CKD than in renal transplant recipients and healthy controls (P < 0.01). Patients with severe proteinuria had a higher cathepsin L activity compared to those with moderate or mild proteinuria (P < 0.01). Serum cathepsin L activity positively associated with age, body mass index, nitrite level, neutrophil count, high-sensitivity C-reactive protein (hs-CRP), N-terminal pro-brain natriuretic peptide, high-mobility group box-1 protein (HMGB1) and 24-h proteinuria. In the ROC analysis, the sensitivity of cathepsin L activity in diagnosis of moderate and heavy is 0.86 and the specificity is 0.73. Moreover, CKD patients with higher cathepsin L activity had a significantly higher hospital admission rate. The data also showed patients with statin administration present significantly lower cathepsin L activity (P < 0.01), hs-CRP (P < 0.01), HMGB1 (P < 0.01) and proteinuria (P < 0.01) compared to non-statin treatment group.
Conclusion:
This study revealed that serum cathepsin L activity is significantly elevated in CKD patients and its level correlates with the severity of proteinuria as well as prognosis, suggesting that serum cathepsin L may serve as a potential biomarker for CKD. Further prospective study is needed to explore its clinical implications in the future.
More Related Videos
10:31Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
19:16The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis
Published on: March 17, 2010
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Nephrotic Syndrome II : Assessment and Medical Management
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Nephrotic Syndrome I : Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention